Top Markets
Coin of the day
Vincerx Pharma, Inc. Vincerx Pharma, Inc.

Vincerx Pharma, Inc.

VINC
Kedudukan dalam Saham #40877
Vincerx Pharma, Inc. is a biopharmaceutical firm currently in the clinical... Vincerx Pharma, Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to discovering and advancing innovative treatments for cancer, specifically addressing areas of high medical need within the U.S. Its primary therapeutic asset is VIP152, an inhibitor targeting cyclin-dependent kinase-9 (CDK9), designed for individuals battling advanced forms of cancer. Beyond this lead candidate, the company's pipeline features several preclinical-stage projects: VIP217, an orally administered PTEFb/CDK9 inhibitor; VIP236, a small molecule drug conjugate aimed at solid tumor treatment; and VIP943 and VIP924, both geared towards treating blood cancers. Established in 2019, Vincerx Pharma is based in Palo Alto, California.
Harga Saham
$0.013
Disegerakkan terakhir: 2026-08-12
Modal Pasaran
$68.05K
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
-66.67%
Negara
US
Perdagangan Vincerx Pharma, Inc. (VINC)

Kategori

Sejarah pecahan saham untuk Vincerx Pharma, Inc. (VINC)
Saham Vincerx Pharma, Inc. (simbol: VINC) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 13, 2026.
Satu saham VINC yang dibeli sebelum Aug 13, 2026 kini bersamaan dengan 0 saham VINC.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE